Efficacy, safety, and tolerability of oxcarbazepine monotherapy

Epilepsy and Behavior

Volumn 9, Issue 3, 2006, Pages 448-456

  Martinez, Walter ^a   Ingenito, Allan ^b   Blakeslee, Mark ^c   Barkley, Gregory L ^d   McCague, Kevin ^e   D'Souza, Joseph ^e  

^a Premiere Research Institute   (United States)

^b Mercy Health Care Center   (United States)

^c Evangelical Community Hospital   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Carbamazepine; Epilepsy; Monotherapy; Oxcarbazepine; Switching

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; SCHOOL CHILD; SOMNOLENCE; SUICIDAL IDEATION; THORAX PAIN; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33750298632     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.04.022     Document Type: Article

References (16)

1. Beydoun A., Sachdeo R.C., Rosenfeld W.E., et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 54 (2000) 2245-2251
2. Sachdeo R., Beydoun A., Schachter S., et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 57 (2001) 864-871
3. Schachter S.C., Vazquez B., Fisher R.S., et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 52 (1999) 732-737
4. Sachdeo R., Edwards K., Rosenfield W., Abou-khali B., Zhou L., and D'Souza J. Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent onset partial epilepsy. Neurology 52 Suppl. 2 (1999) A391
5. Guerreiro M.M., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27 (1997) 205-213
6. Bill P.A., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 27 (1997) 195-204
7. Dam M., Ekberg R., Loyning Y., Waltimo O., and Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 3 (1989) 70-76
8. Christe W., Kramer G., Vigonius U., et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 26 (1997) 451-460
9. Sachdeo RC, Gates JR, Bazil CW, et al. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. Epilepsy Behav 2006;8: in press.
10. ®) prescribing information, Novartis Pharmaceuticals Physicians Desk Reference 2005. Thompson Healthcare, Montvale, NJ.
11. Kwan P., and Brodie M. Epilepsy after the first drug fails: substitution or add-on?. Seizure 9 (2000) 464-468
12. Morrell M.J., Leppik I., French J., Ferrendelli J., Han J., and Magnus L. The KEEPER™ trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study. Epilepsy Res 54 (2003) 153-161
13. Beydoun A., and Kutluay E. Oxcarbazepine. Expert Opin Pharmacol 3 (2002) 59-71
14. ®) on a named-patient basis. Epilepsy Res 19 (1994) 79-85
15. Stefani A., Pisani A., De Murtas M., Mercuri N.B., Marciani M.G., and Calabresi P. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system: II. Modulation of high-voltage-activated calcium currents. Epilepsia 36 (1995) 997-1002
16. Faught E., Sachdeo R.C., Remler M.P., et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 43 (1993) 688-692